Lucentis® eye injections work to treat diabetic macular edema, or swelling of the macula-a leading cause of vision loss associated with diabetes. “This is really good news for our diabetic patients who are experiencing diabetic eye problems,” commented Andreas Wolter, M.D. of Seeta Eye Centers in Poughkeepsie, Fishkill and Carmel, New York. Lucentis® has been used for some time to is to treat “wet” age-related macular degeneration (AMD) and now Lucentis® is the first drug FDA approved to treat diabetic macular edema. More than 500,000 people in the U.S. have diabetic eye disease and before Lucentis® had to have laser treatment to address this complication of diabetic retinopathy. “The use of Lucentis® to treat diabetic macular edema gives us a great tool and a significant advantage is managing vision loss from diabetes,” commented Dr. Wolter. “As we well know, the key to preservation of eye health and vision for diabetics is early detection, diagnosis and treatment.”
If you or someone you know has questions or needs an eye exam for diabetic eye disease or the problems from diabetic retinopathy and diabetic retinopathy please feel free to call
Seeta Eye Centersis conveniently located at 23 Davis Avenue Poughkeepsie, New York 12524 and 664 Stoneleigh Avenue, Suite 100, Carmel, New York 10512.